Tag: CBT > Medical Cannabis Research Cannabinoids: Page 7

Interviews & Opinion

Trait Biosciences Unveils Fully Water-Soluble Cannabinoids

The tasteless, odorless cannabinoids will more easily mix into edibles, beverages and more.

June 10, 2019

Advocacy for Cannabis Legalization

NFL and Players’ Union to Study Potential Use of Marijuana for Pain Management

The exploration will take place within a new medical committee formed by the league and union that will provide recommendations on key medical issues.

May 21, 2019

Legislation and Regulation

FDA Plans Hearings on CBD Policy

Following hemp legalization in the U.S., the FDA must now figure out how to regulate hemp-derived CBD as a food and beverage ingredient.

March 1, 2019

Industry Headlines

FSD Pharma Announces Signing of LOI With Solarvest to Develop, Test Pharma-Grade Cannabinoids Out of Algae

The pharma-grade process could reduce the production time for targeted cannabinoid molecules.

February 5, 2019

Interviews & Opinion

Using Cannabis Science to Build Customer Trust: Q&A With Andrea Sparr-Jaswa

Farma PDX’s director of education explains the benefits of losing the indica/sativa dichotomy and instead focusing on cannabinoid and terpene content.

January 23, 2019

Finance

Resinco Capital Partners Announces Remaining Acquisition of ReFormation Pharmaceuticals Corp

ReFormation is developing a therapeutic to repair vital organs by combining cannabinoids and re-engineering a molecule, HMGB1.

January 16, 2019

Distribution

DEA Greenlights Epidiolex. What’s Next for CBD and the Cannabis Industry?

With the DEA signaling a willingness to join the FDA in approving certain cannabis-derived drugs for sale, the industry looks ahead to more tidal shifts.

September 28, 2018

Industry Headlines

CURE Grants Canopy Growth Rights to Its Proprietary Drug Delivery Technology in Global Markets

Canopy will have an exclusive license to CURE’s CUREfilm technology for use with cannabis extracts and biosynthetic cannabinoids in markets around the world.

September 5, 2018

Finance

Cannabis Stocks Fly Even Higher After Cronos Details ‘Landmark Partnership’

The partnership with Boston-based Ginko Bioworks will seek to produce specific cannabinoids at scale.

September 5, 2018

Distribution

Canada-Based LiveWell Signs $35-Million Cannabinoid Supply Deal in Brazil

The company will supply a minimum 5,000 kilograms of isolated CBD annually to the South American market.

August 24, 2018

California

California Lawsuit Alleges Business Fraud in Cannabis Industry Partnership

H2 Partners asserts that United Cannabis Corporation misled them in a CBD production enterprise.

August 22, 2018

Industry Headlines

FSD Pharma and SciCann Therapeutics Launch Clinical Research Program in Israel

FSD Pharma and SciCann will execute a series of rigorous, randomized, placebo-controlled clinical studies to demonstrate the safety and efficacy of SciCann's products.

August 16, 2018